|
| 36047604 | Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET. | Alzheimers Dement | 2023 |
| 38032638 | Economic Evaluation of Exercise or Cognitive and Social Enrichment Activities for Improved Cognition After Stroke. | JAMA Netw Open | 2023 |
| 35614521 | Brain Imaging Abnormalities in Mixed Alzheimer's and Subcortical Vascular Dementia. | Can J Neurol Sci | 2023 |
| 37386798 | Psychotic symptoms in frontotemporal dementia with TDP-43 tend to be associated with type B pathology. | Neuropathol Appl Neurobiol | 2023 |
| 37385628 | A Systematic Review of the Genetics and Pathology of Psychosis in Frontotemporal Dementia. | Can J Neurol Sci | 2023 |
| 37013586 | Aerobic exercise improves executive functions in females, but not males, without the BDNF Val66Met polymorphism. | Biol Sex Differ | 2023 |
| 37171635 | Limbic-predominant age-related TDP-43 proteinopathy (LATE-NC) is associated with abundant TMEM106B pathology. | Acta Neuropathol | 2023 |
| 37431188 | Network Connectivity Alterations across the MAPT Mutation Clinical Spectrum. | Ann Neurol | 2023 |
| 36695071 | Amyloid-PET of the white matter: Relationship to free water, fiber integrity, and cognition in patients with dementia and small vessel disease. | J Cereb Blood Flow Metab | 2023 |
| 36919891 | Expert elicitation of risk factors for progression to dementia in individuals with mild cognitive impairment. | Alzheimers Dement | 2023 |
| 36931477 | Elicited clinician knowledge did not improve dementia risk prediction in individuals with mild cognitive impairment. | J Clin Epidemiol | 2023 |
| 36151869 | Amyloid-Related Imaging Abnormalities in the DIAN-TU-001 Trial of Gantenerumab and Solanezumab: Lessons from a Trial in Dominantly Inherited Alzheimer Disease. | Ann Neurol | 2022 |
| 35349636 | Proposed research criteria for prodromal behavioural variant frontotemporal dementia. | Brain | 2022 |
| 35790423 | Differences in Motor Features of <i>C9orf72</i>, <i>MAPT</i>, or <i>GRN</i> Variant Carriers With Familial Frontotemporal Lobar Degeneration. | Neurology | 2022 |
| 35783127 | Avoid or Embrace? Practice Effects in Alzheimer's Disease Prevention Trials. | Front Aging Neurosci | 2022 |
| 36632182 | White-matter abnormalities in presymptomatic <i>GRN</i> and <i>C9orf72</i> mutation carriers. | Brain Commun | 2022 |
| 36199154 | Müller cell degeneration and microglial dysfunction in the Alzheimer's retina. | Acta Neuropathol Commun | 2022 |
| 36227593 | Effect of Exercise Training or Complex Mental and Social Activities on Cognitive Function in Adults With Chronic Stroke: A Randomized Clinical Trial. | JAMA Netw Open | 2022 |
| 36085237 | Reshaping the path of mild cognitive impairment by refining exercise prescription: a study protocol of a randomized controlled trial to understand the "what," "for whom," and "how" of exercise to promote cognitive function. | Trials | 2022 |
| 33247623 | Brain volumetric deficits in MAPT mutation carriers: a multisite study. | Ann Clin Transl Neurol | 2021 |
| 33523006 | Exploring the Contribution of Myelin Content in Normal Appearing White Matter to Cognitive Outcomes in Cerebral Small Vessel Disease. | J Alzheimers Dis | 2021 |
| 33490361 | Frontotemporal dementia and COVID-19: Hypothesis generation and roadmap for future research. | Alzheimers Dement (N Y) | 2021 |
| 33857770 | Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia. | Cortex | 2021 |
| 34912492 | Consensus Statement Regarding the Application of Biogen to Health Canada for Approval of Aducanumab. | Can Geriatr J | 2021 |
| 34620933 | Cardiovascular risk moderates the effect of aerobic exercise on executive functions in older adults with subcortical ischemic vascular cognitive impairment. | Sci Rep | 2021 |
| 34155411 | A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. | Nat Med | 2021 |
| 34027019 | Clinico-pathological comparison of patients with autopsy-confirmed Alzheimer's disease, dementia with Lewy bodies, and mixed pathology. | Alzheimers Dement (Amst) | 2021 |
| 34049163 | FDG-PET in presymptomatic C9orf72 mutation carriers. | Neuroimage Clin | 2021 |
| 31272932 | Individualized atrophy scores predict dementia onset in familial frontotemporal lobar degeneration. | Alzheimers Dement | 2020 |
| 31810826 | Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. | Lancet Neurol | 2020 |
| 31784375 | Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration. | Alzheimers Dement | 2020 |
| 31636026 | The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology. | Alzheimers Dement | 2020 |
| 31914230 | Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint. | Alzheimers Dement | 2020 |
| 31914218 | Utility of the global CDR[®] plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium. | Alzheimers Dement | 2020 |
| 31914217 | Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases. | Alzheimers Dement | 2020 |
| 33209972 | CCCDTD5 recommendations on early and timely assessment of neurocognitive disorders using cognitive, behavioral, and functional scales. | Alzheimers Dement (N Y) | 2020 |
| 32656921 | Quality of life and caregiver burden in familial frontotemporal lobar degeneration: Analyses of symptomatic and asymptomatic individuals within the LEFFTDS cohort. | Alzheimers Dement | 2020 |
| 32848548 | Amyloid Beta Immunoreactivity in the Retinal Ganglion Cell Layer of the Alzheimer's Eye. | Front Neurosci | 2020 |
| 32617385 | An automated clinical mass spectrometric method for identification and quantification of variant and wild-type amyloid-β 1-40 and 1-42 peptides in CSF. | Alzheimers Dement (Amst) | 2020 |
| 32366785 | The Use of Random Forests to Identify Brain Regions on Amyloid and FDG PET Associated With MoCA Score. | Clin Nucl Med | 2020 |
| 32488697 | Trehalose Inhibits Aβ Generation and Plaque Formation in Alzheimer's Disease. | Mol Neurobiol | 2020 |
| 29023987 | Prevalence of delusions in drug-naïve Alzheimer disease patients: A meta-analysis. | Int J Geriatr Psychiatry | 2019 |
| 31872042 | Nonlinear Z-score modeling for improved detection of cognitive abnormality. | Alzheimers Dement (Amst) | 2019 |
| 31707213 | Generation of an induced pluripotent stem cell line (UBCi001-A) from a presymptomatic individual carrying the R418X progranulin gene mutation. | Stem Cell Res | 2019 |
| 31244341 | Clinicopathologic correlations in a family with a <i>TBK1</i> mutation presenting as primary progressive aphasia and primary lateral sclerosis. | Amyotroph Lateral Scler Frontotemporal Degener | 2019 |
| 31585367 | Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers. | Neurobiol Aging | 2019 |
| 31348088 | The Use of Random Forests to Classify Amyloid Brain PET. | Clin Nucl Med | 2019 |
| 31309917 | The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort Study. | Can J Neurol Sci | 2019 |
| 30741682 | Cerebral Amyloid-β Deposition Is Associated with Impaired Gait Speed and Lower Extremity Function. | J Alzheimers Dis | 2019 |
| 30867079 | The Effect of Aerobic Exercise on White Matter Hyperintensity Progression May Vary by Sex. | Can J Aging | 2019 |